APA (7th ed.) Citation

S, K., BR, B., SA, C., & A, V. (2026). Prophylactic Neurokinin-1 Receptor Antagonist Use Pre- and Post-Choosing Wisely Initiative Among Women With Invasive Breast Cancer. Health services research, 61(2), e14626. https://doi.org/10.1111/1475-6773.14626

Chicago Style (17th ed.) Citation

S, Kamat, Brown BR, Cohen SA, and Vyas A. "Prophylactic Neurokinin-1 Receptor Antagonist Use Pre- and Post-Choosing Wisely Initiative Among Women With Invasive Breast Cancer." Health Services Research 61, no. 2 (2026): e14626. https://doi.org/10.1111/1475-6773.14626.

MLA (9th ed.) Citation

S, Kamat, et al. "Prophylactic Neurokinin-1 Receptor Antagonist Use Pre- and Post-Choosing Wisely Initiative Among Women With Invasive Breast Cancer." Health Services Research, vol. 61, no. 2, 2026, p. e14626, https://doi.org/10.1111/1475-6773.14626.